FindTrial
Sign In

Risperdal

DRUG4 trials

Sponsors

University of Maryland, Baltimore, Ohio State University, Washington University School of Medicine, University of Geneva, Switzerland

Conditions

22q11.2 Deletion SyndromeAdjustment DisorderAttention Deficit/Hyperactivity Disorder (ADHD)Bipolar DisorderConduct DisorderDiabetesImpulse-Control DisordersIntermittent Explosive Disorder

Phase 2

Metabolic Effects of Antipsychotic Substitution in Children
WithdrawnNCT00910780
Washington University School of MedicineDiabetes
Start: 2009-11-30End: 2009-11-30Updated: 2014-03-13

Phase 3

Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.
CompletedNCT00399698
Ohio State UniversityAdjustment Disorder, Attention Deficit/Hyperactivity Disorder (ADHD), Bipolar Disorder +5
Start: 1999-05-31End: 2005-06-30Target: 30Updated: 2016-06-23

Phase 4

Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine
CompletedNCT00056498
University of Maryland, BaltimoreSchizophrenia
Start: 2001-12-31End: 2007-12-31Updated: 2019-10-01

Unknown Phase

Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion Syndrome
TerminatedNCT04639960
University of Geneva, Switzerland22q11.2 Deletion Syndrome
Start: 2017-09-29End: 2021-05-01Updated: 2024-12-06

Related Papers

Effects of risperidone on psychotic symptoms and cognitive functions in 22q11.2 deletion syndrome: Results from a clinical trial
Frontiers in Psychiatry2022-10-265 citations
Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine.
2010-07-2130 citations